Sanara MedTech Inc. (SMTI) stock analysis

In our weekly check, Sanara MedTech Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 5, red flags: 6.

Sector: Healthcare · Medical Instruments & Supplies

Strengths

• Margins rising
• Profits backed by cash
• High return on capital

Warning signs

• High debt
• Weak interest cover
• Weak EPS growth
• Thin margins
• Very volatile

Next earnings report: 2026-11-11

Similar companies

STAA · KMTS · AZTA · XRAY · LMAT · ATRC

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis